0001652917-16-000011.txt : 20160519 0001652917-16-000011.hdr.sgml : 20160519 20160519162635 ACCESSION NUMBER: 0001652917-16-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160517 FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Plew Daniel P CENTRAL INDEX KEY: 0001411984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 161663482 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-05-17 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001411984 Van Plew Daniel P 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP & General Mgr Industrial O Common Stock 2016-05-17 4 M 0 9460.0 30.63 A 11381 D Common Stock 2016-05-17 4 F 0 746.0 388.14 D 10635 D Common Stock 2016-05-17 4 F 0 4301.0 388.14 D 6334 D Common Stock 2016-05-18 4 S 0 4413.0 385.77 D 1921 D Common Stock 18705 I by GRAT Common Stock 1444 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2016-05-17 4 M 0 9460.0 0.0 D 2020-12-14 Common Stock 9460 32735 D Represents volume-weighted average price of sales of 4,413 shares of Company stock on May 18, 2016 at prices ranging from $385.66 to $385.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 18, 2016 at each separate price. The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013. /s/**Daniel P. Van Plew 2016-05-19